Exercise capacity in patients with psoriasis assessed by cardiopulmonary exercise testing: a case-control study
Anais Brasileiros de Dermatologia · 2026-11 · 101 (6) · 501470
DOI: 10.1016/j.abd.2026.501470 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-11. Verfasst von Hanife Baykal Şahin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. Electronic address: baykalh…. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Psoriasis is a systemic inflammatory disease associated with cardiovascular and metabolic comorbidities. Although reduced physical activity is frequently reported in these patients, objective data on physiological exercise capacity remains limited. OBJECTIVE: To evaluate exercise capacity in patients with psoriasis using Cardiopulmonary Exercise Testing (CPET), the gold standard method, and compare the results with those of healthy controls. METHODS: This cross-sectional study included 32 patients with psoriasis (off systemic therapy for ≥6-months) and 33 age- and sex-matched healthy controls. Participants underwent symptom-limited CPET on a cycle ergometer. Disease severity was assessed using the Psoriasis Area and Severity Index (PASI), and Physician Global Assessment (PGA). RESULTS: Patients with psoriasis demonstrated significantly lower exercise capacity compared to controls. Peak VO₂, percentage of predicted peak VO₂, VO₂ at AT, and work rate were all significantly lower (all p < 0.01). Peak VO₂ showed significant negative correlations with BMI, PASI, and PGA (all p ≤ 0.001). In multiple linear regression analysis, age (β = -0.17, p = 0.017), BMI (β = -0.30, p = 0.007), and PASI score (β = -0.47, p = 0.001) were identified as independent predictors of peak VO₂, explaining 63.4% of its variance (R² = 0.634, p < 0.001). STUDY LIMITATIONS: The cross-sectional design and relatively small single-center sample limit causal inference. CONCLUSIONS: Patients with psoriasis demonstrated reduced exercise capacity compared with healthy controls, and disease severity was independently associated with lower peak VO₂. However, due to the cross-sectional design and the potential influence of unmeasured cardiometabolic and lifestyle-related confounders, causality cannot be established, and further prospective studies are required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey. Electronic address: baykalhanife@ktu.edu.tr.
- Department of Dermatology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Zitieren
APA
Baykal Şahin, H., Ferhatosmanoğlu, A., & Baykal Selçuk, L. (2026). Exercise capacity in patients with psoriasis assessed by cardiopulmonary exercise testing: a case-control study. Anais Brasileiros de Dermatologia, 101(6), 501470. https://doi.org/10.1016/j.abd.2026.501470
Vancouver
Baykal Şahin H, Ferhatosmanoğlu A, Baykal Selçuk L. Exercise capacity in patients with psoriasis assessed by cardiopulmonary exercise testing: a case-control study. Anais Brasileiros de Dermatologia. 2026;101(6):501470. doi:10.1016/j.abd.2026.501470
BibTeX
@article{Baykalahin2026,
author = {Baykal Şahin, Hanife and Ferhatosmanoğlu, Arzu and Baykal Selçuk, Leyla},
title = {Exercise capacity in patients with psoriasis assessed by cardiopulmonary exercise testing: a case-control study},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {6},
pages = {501470},
doi = {10.1016/j.abd.2026.501470}
}
EUVIMED